Women who take a low dose of aspirin every day might have a 23% lower risk of developing ovarian cancer than those who don't take aspirin, according to the results of a study by researchers at the Moffitt Cancer Center, the Huntsman Cancer Institute, and the Harvard T.H. Chan School of Public Health. The research team, which analyzed data from more than 200000 women in the Nurses’ Health Studies, at Brigham and Women’s Hospital, say the results showed that the protective effects of aspirin only appear to be evident at low dose, not standard dose, while heavy, prolonged use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of ovarian cancer. We're not quite at the stage where we could make the recommendation that daily aspirin use lowers ovarian cancer risk,” says research lead Shelley Tworoger, Ph.D., associate center director for population science at Moffitt. “We need ...
Original Article: Ovarian Cancer Risk Reduced by Low-Dose Aspirin Use